Polymeric Micelle Nanocarriers for the Cutaneous Delivery of Tacrolimus: A Targeted Approach for the Treatment of Psoriasis

    July 2014 in “ Molecular pharmaceutics ”
    Maria Lapteva, Karine Mondon, Michael Möller, Robert Gurny, Yogeshvar N. Kalia
    TLDR New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.
    The study aimed to improve the cutaneous delivery of tacrolimus (TAC) for psoriasis treatment by formulating TAC-loaded polymeric micelles using the biodegradable and biocompatible MPEG-dihexPLA diblock copolymer. The optimal 0.1% micelle formulation was stable for 7 months at 4 °C, with diameters ranging from 10 to 50 nm. Delivery experiments using human skin showed significantly greater TAC deposition with the micelle formulation compared to Protopic ointment (1.50 ± 0.59 vs. 0.47 ± 0.20 μg/cm²). The increased TAC levels were localized in the stratum corneum, viable epidermis, and upper dermis without deeper skin penetration or systemic absorption, suggesting reduced side effects. Confocal laser scanning microscopy confirmed micelle deposition in hair follicles and indicated that micelle release depended on the molecular properties of the cargo. The results demonstrated that MPEG-dihexPLA micelles are highly efficient for selective cutaneous TAC delivery and have potential for targeted hair follicle delivery.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results

    Related Community Posts Join

    6 / 20 results

      community Medications that cause extra hair growth

      in Research/Science  123 upvotes 2 years ago
      The post discusses the side effects of various drugs causing excess hair growth, questioning why only minoxidil is used in the hair loss industry. The conversation includes users sharing their experiences and concerns about potential side effects of these drugs, with some preferring baldness over potential health risks.

      community The MPB itch aka DHT itch is very real.

      in Chat  9 upvotes 3 years ago
      Hair loss itch is caused by DHT attacking follicles and stimulating nerves. Finasteride users who respond well don't experience this itch.

      community Breaking hair loss news! GT20029 is a resounding success!

      in Product  132 upvotes 1 year ago
      GT20029, a new hair loss treatment, shows promising results but only a slight improvement over placebo. People are cautiously optimistic, discussing its potential and combining it with existing treatments like Minoxidil and Finasteride.

      community I had claude create a protocol only using fda approved drugs.

      in Research/Science  2 upvotes 2 months ago
      A new hair loss protocol using FDA-approved topical treatments targets eight pathways, potentially improving results by 60-75% compared to the standard 40-50% from oral minoxidil and finasteride. The protocol includes minoxidil, finasteride, tacrolimus, cetirizine, bimatoprost, lithium gluconate, losartan, melatonin, NAC, caffeine, and tretinoin, with a monthly cost of $35-50 in Mexico and $80-150 in the US.

    Similar Research

    5 / 1000+ results